CTO Realty Growth Inc
Real Estate
CTO Realty Growth Inc (CTO) Stock News
The latest CTO headlines and market coverage — 7 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
Inspire Medical Systems presented new clinical data at SLEEP 2026 demonstrating the effectiveness of its Inspire V hypoglossal nerve stimulation system for obstructive sleep apnea treatment. Key findings include significant reductions in hypoxic burden, improved cardiovascular outcomes compared to CPAP therapy, and higher patient adherence rates. The company also published studies identifying predictors for therapy eligibility and presented results from its 5,000-patient ADHERE registry showing 62% median AHI reduction.
- Benzinga·
TOURMALINE DECLARES QUARTERLY DIVIDEND AND ANNOUNCES ELECTION OF DIRECTORS
Tourmaline Oil Corp. announced a quarterly cash dividend of $0.50 per share payable on June 30, 2026, and held its annual shareholder meeting on June 3, 2026, where ten directors were elected. The company is Canada's largest natural gas producer focused on low-cost development in the Western Canadian Sedimentary Basin.
- GlobeNewswire Inc.·
CTO Realty Growth Announces the Sale of an Atlanta Asset for $73.3 Million
CTO Realty Growth announced the sale of Madison Yards, a 163,000-square-foot grocery-anchored shopping center in Atlanta, for $73.3 million ($451 per square foot). The company plans to redeploy capital into higher-yielding opportunities, including a recent $81.6 million acquisition of Palms Crossing in Texas and an anticipated $53 million power center acquisition in the Dallas metro area. The sale also reduces the company's AMC Theaters exposure.
- GlobeNewswire Inc.·
UMH PROPERTIES, INC. CONGRATULATES ITS DIRECTORS ON THEIR REELECTION AT THE ANNUAL SHAREHOLDER MEETING
UMH Properties, Inc. announced the reelection of its four directors at the 2026 annual shareholder meeting. The company highlighted strong performance with a 16.4% three-year total shareholder return and 159.5% ten-year return, positioning it among top-performing REITs. UMH also received multiple industry awards including Community Operator of the Year for the fifth time from the Manufactured Housing Institute.
- Benzinga·
CTO Realty Growth Declares Dividends for the Second Quarter 2026
CTO Realty Growth announced a quarterly cash dividend of $0.38 per share of common stock for Q2 2026, representing an annualized yield of approximately 7.4%. The company also declared a dividend of $0.39844 per share for its 6.375% Series A Cumulative Redeemable Preferred Stock. Both dividends are payable on June 30, 2026, to stockholders of record as of June 11, 2026.
- Benzinga·
SEEGNAL INC. ANNOUNCES FILING OF 2025 ANNUAL FILINGS AND THAT THE MCTO WILL NO LONGER BE IN EFFECT AS OF MAY 16, 2026
CALGARY, AB, May 17, 2026 (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN ) (" Seegnal " or the " Company ") announces that the management cease trade order (the " MCTO "), issued by the Alberta Securities Commission on May 8, 2026, at the request of the Company, will no longer be in effect as of May 16, 2026. On May 13, 2026, the Company filed its audited consolidated financial statements for the year ended December 31, 2025, together with the related management's discussion and analysis and the Chief Executive Officer and the Chief Financial Officer certifications. The MCTO applied only to the Chief Executive Officer and the Chief Financial Officer and did not affect the ability of the general investing public to trade in the Company's securities. The Company confirms that it is current with its continuous disclosure obligations and anticipates meeting its future filing requirements. About Seegnal Seegnal is a public company that aims to solve one of the top causes of death and injuries in the modern world – Adverse Drug Effects (ADEs). Seegnal's Clinical Decision Support system introduces a paradigm shift in the approach to this problem by implementing a new elevated Patient-Centric Standard. Seegnal's SaaS technology exclusively integrates at the point-of-care, unique patient-specific data like genetics, results of lab tests, ECG, smoking, allergies, food, gender, age, and the effects of many concomitant medications, while reducing the current alert load for clinicians ... Full story available on Benzinga.com
- GlobeNewswire Inc.·Neutral
SEON Appoints Sagnik Nandy, CTO of Docusign, to Board of Directors
SEON announced the appointment of Sagnik Nandy, CTO at Docusign and former engineering leader at Google and Okta, to its Board of Directors. Nandy brings 15+ years of experience in enterprise technology, AI infrastructure, and identity management. His appointment reflects SEON's focus on scaling its AI-driven fraud prevention, identity verification, and AML compliance platform globally.